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and metabolic disorders”, and “eating disorders and meta-
bolic disorders”. Based on inclusion criteria (concerning 
a clear psychiatric disorder and concerning a metabolic 
disorder) 4441 titles and 249 abstracts were screened and 
resulted in 71 relevant articles. This thorough literature 
search provides child and adolescent psychiatrists with 
an overview of metabolic disorders associated with child 
psychiatric symptoms, their main characteristics and rec-
ommendations for further investigations.
Keywords Metabolic disorders · Child psychiatric 
disorder · ASD · ADHD · Learning disorder · Psychosis · 
Eating disorder
Abbreviations
OXPHOS  Oxidative phosphorylation
OTCD  Ornithine transcarbamylase deficiency
3-OH-IVA  3-hydroxyisovaleric acid
Introduction
Although a lot of research has already been done about 
organic causes of child psychiatric disorders, few of them 
focus on metabolic disorders as a possible cause of a child 
psychiatric disorder. Many children who visit our centre 
for hereditary metabolic diseases suffer from a child psy-
chiatric disorder [1]. Metabolic disorders cover a variety of 
diseases in which there is an accumulation of toxic and/or 
complex compounds or energy problems within the cells 
due to enzymatic defects or other protein dysfunction (e.g., 
transporter defects).
Sometimes the psychiatric symptoms occur before 
irreversible neurological lesions. A number of metabolic 
disorders give rise to a major psychiatric disorder. These 
Abstract Many patients who visit a centre for heredi-
tary metabolic diseases remarkably also suffer from a 
child psychiatric disorder. Those child psychiatric disor-
ders may be the first sign or manifestation of an underly-
ing metabolic disorder. Lack of knowledge of metabolic 
disorders in child psychiatry may lead to diagnoses being 
missed. Patients therefore are also at risk for not accessing 
efficacious treatment and proper counselling. To search 
the literature for the co-occurrence of child psychiatric 
disorders, such as ADHD, autism, psychosis, learning 
disorders and eating disorders and metabolic disorders. 
A search of the literature was conducted by performing 
a broad search on PubMed, using the terms “ADHD and 
metabolic disorders”, “autism and metabolic disorders”, 
“psychosis and metabolic disorders”, “learning disorders 
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metabolic disorders can result in neuropsychiatric illness 
either through disruption of late neurodevelopmental pro-
cesses, or via chronic or acute disruption of excitatory/
inhibitory or monoaminergic neurotransmitter systems. 
This disruption to metabolic processes can lead to gross 
neurodevelopmental disruption with seizures and coma, 
or to mild disruption with intermittent and/or subtle cog-
nitive, behavioural disturbance and psychiatric illness, 
such as psychosis [2]. To prevent or decrease mortality, 
morbidity and disabilities associated with metabolic dis-
eases as much as possible, it is important to detect the 
metabolic disease as early as possible. For this reason, 
it is important that child and adolescent psychiatrists are 
aware of possible underlying metabolic disease in child 
psychiatric problems. This is of great importance because 
specific treatment may be available to prevent metabolic 
decompensation and further progression of disease can be 
avoided. In addition, many of these conditions have impor-
tant implications for genetic counselling. This article gives 
an overview of the literature on co-occurring metabolic 
disorders and child psychiatry disorders and attempts to 
give child psychiatrists some recommendations on when to 
screen for metabolic disorders.
Method
We searched PubMed for articles published between 1 Janu-
ary 1980 and 31 December 2013, using the search terms: 
“ADHD and metabolic disorders”, “autism and metabolic 
disorders”, “psychosis and metabolic disorders”, “learn-
ing disorders and metabolic disorders”, and “eating disor-
ders and metabolic disorders”. Concerning psychosis, we 
included articles about visual auditory or visual hallucina-
tions, paranoid delusions, interpretative thoughts and schiz-
ophrenia. Articles were selected according the following 
criteria: (1) articles were written in English, (2) the article 
concerned a clear psychiatric disorder according the DSM-
criteria and concerned a metabolic disorder, and (3) the arti-
cle was not about a metabolic syndrome.
Our search resulted in 4441 initial hits, after screening 
titles and abstracts for inclusion and exclusion criteria, we 
studied the remaining 249 articles and concluded that only 
71 were actually relevant (and not concerning the meta-
bolic syndrome). Figure 1 shows the flow diagram that was 
used for all psychiatric disorders in the literature search; 
Table 1 specifies the search results for each psychiatric dis-
order separately.
Fig. 1  Flow diagram showing 
process of literature search
Search by pubmed for type of psychiatric disorder and 
metabolic disorders
N=4441
Selection by abstract based on the criteria
a) Concerning a clear psychiatric disorder of 
interest
b) Concerning a metabolic disorder
Based on these criteria the full text was viewed
N=249
Full text fulfilling the above mentioned criteria was 
analyzed and conclusions of interest for the current 
review are included in the paper
N= 71
Exclusion of articles about 
metabolic syndrome and not 
meeting the inclusion criteria 
Exclusion of papers not meeting 
the inclusion criteria
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Psychiatric disorders such a depression and anxiety dis-
orders were not included in the search because based on 
clinical experience and earlier research [1], we expect these 
disorders rather to be a consequence of dealing with the 
diagnosis of and life with a metabolic disease than that they 
share a common underlying disruption.
Literature search
There is a lack of review articles on the subject. Only three 
reviews on psychiatric symptoms and metabolic disorders 
were found.
One by Sedel et al. [3] proposed a classification of met-
abolic diseases into three groups according to the type of 
psychiatric signs at onset. Group 1 represents psychiatric 
emergencies, namely acute and recurrent attacks of confu-
sion and behavioural changes, sometimes misdiagnosed as 
acute psychosis. This includes urea cycle defects, homo-
cysteine remethylation defects and porphyrias. Group 2 
includes diseases with chronic psychiatric symptoms aris-
ing in adolescence or adulthood. These psychiatric symp-
toms can be recurrent psychotic attacks, chronic delusion 
or disorganized behaviour, and behavioural and personal-
ity changes. Among these diseases are homocystinurias, 
Wilson disease, adrenoleukodystrophy and some lysoso-
mal storage disorders. Group 3 is characterized by mild 
mental retardation and late-onset behavioural or person-
ality changes. This group includes homocystinurias, cer-
ebrotendinous xanthomatosis, nonketotic hyperglycinemia, 
monoamine oxidase A deficiency, succinic semialdehyde 
dehydrogenase deficiency, creatine transporter defect, and 
alpha-/beta-mannosidosis. In this paper, a diagnostic strat-
egy to guide metabolic investigations in a patient with atyp-
ical psychiatric signs is proposed.
Another article by Estrov et al. [4] reviewed four meta-
bolic diseases: phenylketonuria (PKU), Wilson disease, 
acute intermittent porphyria (AIP) and metachromatic 
leukodystrophy (MLD). Early treated PKU can exhibit 
depressed mood, anxiety (esp agoraphobia) and psychoso-
cial difficulties. Wilson disease can present with personal-
ity changes, depressive episodes, cognitive dysfunction 
and psychosis. AIP is often associated with symptoms of 
anxiety, depression, psychosis and altered mental status as 
psychiatric manifestations. MLD frequently presents with 
psychosis followed by intellectual deterioration.
In 2013, Walterfang et al. [2] wrote a review on the neu-
ropsychiatry of inborn errors of metabolism. In this article, 
following metabolic disorders are also associated with psy-
chiatric symptoms: metachromatic leukodystrophy, GM2 
gangliosidosis, adrenoleukodystrophy, Niemann–Pick 
type C disease, cerebrotendinous xanthomatosis, neuronal 
ceroid lipofuscinosis, alpha-mannosidosis, Fabry disease, 
AIP, maple syrup urine disease, urea cycle disorders, dis-
orders of homocysteine metabolism and PKU. Remarkably, 
there is an increase in reports the latest years about mito-
chondrial dysfunctioning and several neurodevelopment 
disorders, such as ASD, learning disorders, ADHD, schiz-
ophrenia and mood disorders [5, 6]. A mitochondrial dys-
function leads to an energy problem and neural synapses 
are areas of high energy consumption.
Autism spectrum disorders
About the link of autism spectrum disorder (ASD) and met-
abolic disorders four review articles were found [7–9]. In 
these four reviews, concerning ASD and metabolic disor-
ders, similar findings are reported. Known metabolic dis-
orders in autism are phenylketonuria, disorders in purine 
metabolism (such as adenosine deaminase deficiency, ade-
nylosuccinate lyase deficiency, dihydropyrimidine dehydro-
genase and dihydropyrimidinase deficiencies), organic aci-
durias (such as propionic academia, 3-methylcrotonyl-CoA 
carboxylase deficiency and pyridoxine dependency), dis-
orders of branched-chain amino acids creatine deficiency, 
biotinidase deficiency, cerebral folate deficiency, succinic 
semialdehyde dehydrogenase deficiency, Smith–Lemli–
Opitz syndrome (SLOS), late infantile ceroid lipofuscino-
sis, histidinemia, Sanfilippo disease, glucose 6-phosphate 
dehydrogenase deficiency, urea cycle disorders, X-linked 
ichthyosis, and mitochondrial disorders. In most of these 
disorders, there is also mental or psychomotor retardation.
In addition, case reports and some small studies 
about these diseases were found [10–14]. Benvenuto 
Table 1  Results of PubMed search by type of psychiatric disorder
Type of psychiatric disorder Number of titles found Number of abstracts viewed Numbers of articles included for review
ADHD 316 34 10
Autism 559 101 19
Eating disorders 1513 18 5
Learning disorders 726 49 17
Psychosis 1327 47 20
Total (including review) 4441 249 71
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[15] names PKU, adenylosuccinase deficit, SLOS, cre-
atine deficiency syndromes and mitochondrial disorders 
as possible causes of syndromic autism. Case reports 
of autism in association with acute intermittent por-
phyria [16], propionic academia [17] and L-2-hydroxy-
glutaric aciduria [18] were found. Kaluzna-Czaplinska 
[19] focusses on the role of homocysteine in autism. A 
high level of blood and urinary homocysteine is asso-
ciated with pathophysiology of ASD and may serve as 
a diagnostic tool for the detection of nutrient deficien-
cies (folate, vitamin B12) in autistic children. The last 
years several studies were done suggesting a disturbance 
of mitochondrial energy production as an underlying 
pathophysiological mechanism in autism [20–22]. Frye 
[6] states that children with ASD and a mitochondrial 
disorder appear to have a higher prevalence of medical 
disorders such as gastrointestinal problems, seizures 
and gross motor delay. An interesting study was done in 
Greece [23] where they screened 187 children with con-
firmed features of ASD for the presence of inborn errors 
of metabolism. Their data provide evidence for a new 
biomarker (3-OH-IVA) and novel treatment approaches 
in ASD patient. Biotin supplementation or institution 
of a ketogenic diet resulted in mild to significant clini-
cal improvement in the autistic features. Table 2 sum-
marizes, based on the literature, when ASD is combined 
with specific other psychiatric, neurodevelopmental or 
somatic problems with metabolic diseases can be an 
underlying cause.
Attention deficit hyperactivity disorder
The literature search found several studies concerning 
the prevalence of attention deficit hyperactivity disorder 
(ADHD) in persons with a metabolic disorder. Knerr [11] 
studied a population of 33 subjects with succinic semial-
dehyde dehydrogenase deficiency of which 28 % showed 
behavioural problems such as attention deficit and hyper-
activity. In addition, autistic features were found in these 
patients. The patients in this population also have psy-
chomotor retardation. In a population of 25 boys with 
X-linked ichthyosis [14], 40 % fulfilled DSM-IV criteria 
for a diagnosis of ADHD. ADHD in children with PKU is 
well documented in several papers. Antshel [24, 25] stated 
that prenatal exposure to elevated levels of phenylalanine 
is associated with a higher likelihood of expressing hyper-
active/impulsive symptoms and postnatal exposure is asso-
ciated with a higher likelihood of expressing inattentive 
symptoms. Arnold [26] performed a study in 38 children 
with PKU and found that 26 % of this children use stimu-
lant medication for attentional dysfunction, which is sig-
nificantly higher than in an age- and sex-matched control 
group. Case reports of ADHD in a child with a metabolic 
disorder were found for 3-methylcrotonyl-CoA carboxylase 
deficiency [27], argininosuccinate lyase deficiency [28] and 
succinyl-CoA: 3-oxoacid CoA transferase deficiency [29].
Wijburg et al. [30] stated that mucopolysaccharidosis III 
(Sanfilippo disease), which is characterized by progressive 
cognitive decline and severe hyperactivity, is often misdi-
agnosed as an idiopathic developmental delay, ADHD or 
ASS. ADHD is also linked to mitochondrial disorders [5]. 
An overview of the metabolic disorders associated with 
ADHD is summarized in Table 3.
Learning disorders
Taking learning disorders into consideration, some 
reports are found showing a link between learning dis-
orders and adrenoleukodystrophy [31, 32] and MLD 
[33], which is associated with nonverbal learning dis-
ability. Gordon [34] reported about glucose transporter 
type 1 deficiency as a preventable cause of severe learn-
ing difficulties. Children with PKU show lower IQ, slow 
information processing, reduced learning capacity, mild 
executive impairments, and educational difficulties [35]. 
Antshel [24, 25] also reports in a review that young 
adults with PKU are more likely to have academic dif-
ficulties than their non-PKU peers, especially in maths. 
This is due to ADHD but also to executive functioning 
deficits and processing speed deficits. Janzen [36] stated 
that individuals with PKU also have nonexecutive cogni-
tive abilities, such as problems with information speed 
processing, fine motor control, and perception and visual-
spatial abilities. In an American longitudinal observa-
tion with 108 individuals with urea cycle disorders, 35 % 
had learning disabilities [37]. Lichter [38] specified this 
for OTC-deficiency. Special emphasis in this article was 
made on the late-onset (partial) disease, who can present 
from infancy to adulthood. A hyperammonemic crisis can 
lead to a life-threatening event and neuropsychological 
complications, such as developmental delay, ADHD and 
executive function deficits. Potter [39] studied 43 chil-
dren with galactosemia and a history of speech sound dis-
orders. 56 % of the children with typical cognitive devel-
opment and 88 % of the children with borderline-low 
cognitive development showed language impairments. 
The first group had more often an expressive language 
disorder, the second group more often a mixed receptive-
expressive language disorder. Bahi-Buisson [40] exam-
ined 22 patients with hyperinsulinism-hyperammonaemia 
syndrome and found a learning disability in 17 patients. 
Case reports were found about the occurrence of learning 
disorders in glutaric aciduria type I [41] and generalised 
uridine diphosphate galactose-4-epimerase deficiency 
[42]. Learning difficulties are also reported in Niemann-
Pick disease type C [43]. Patients with juvenile neuronal 
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ceroid lipofuscinosis show learning delay and regression 
of acquired skills [44]. Brady [45] described two cases 
with mucopolysaccharidosis type IIIB presenting as chil-
dren with behavioural issues and mild learning disabili-
ties, and having a rapid cognitive decline in early adult-
hood (see Table 4 for an overview).
Psychosis
Psychosis, what can be auditory or visual hallucina-
tions, paranoid delusions, and interpretative thoughts, 
and can be a symptom of schizophrenia, is described 
in alpha-mannosidosis [46, 47] and also in other lyso-
somal storage diseases: late-onset Tay–Sachs disease 
[48] and Fabry disease [49, 50]. Psychosis is also seen 
in mitochondrial disorders, in particular, respiratory 
chain defects [5, 51, 52]. Wilson’s disease can pre-
sent with psychosis, but also as personality and mood 
changes, depression, phobias, cognitive impairment, 
anxiety and compulsive and impulsive behaviour [53–
55]. A clinical presentation of metachromatic leukod-
ystrophy during adolescence and/or adulthood may be 
psychosis [56]. If a post pubertal patient presents with 
acute mental changes and hallucinations or psychosis, 
acute porphyria should be considered [57]. In addi-
tion, a link between a disturbed homocysteine metabo-
lism and schizophrenia is described [58]. Psychosis is 
also described in Niemann-Pick type C [59, 60]. Also, 
behavioural disturbances occur in this disease (see 
Table 5 for an overview).
Eating disorders
Concerning eating disorders and metabolic disorders only 
five relevant articles were found. Touati [61] describes 
frequent feeding disorders in children with methylmalonic 
and propionic acidurias, in which up to 60 % of patients 
needed a food supplement by tube. Deutsch et al. [62] 
report about a woman with anorexia nervosa and a mito-
chondrial myopathy, suggesting the possibility that the 
eating disorder was causally related to a more fundamen-
tal defect in mitochondrial oxidative metabolism. Symp-
toms of anorexia nervosa were also described in MELAS 
[63] and mitochondrial encephalomyopathy [64]. Sedel 
[3] mentions in his review that patients with a urea cycle 
disorder often experience protein intolerance and change 
their food habits becoming vegetarian or anorexic. Also, 
Gardeitchik [65] reports that protein aversion can be a 
diagnostic clue in patients presenting with food refusal, 
recurrent vomiting, behavioural problems, mental retar-
dation and episodes of altered consciousness (see Table 6 
for an overview).
Conclusions
The literature search concerning metabolic disorders and 
child psychiatric disorders was performed. Metabolic dis-
eases represent rare but important causes of psychiatric 
diseases that remain isolated for years before more spe-
cific organic signs become obvious [3]. Psychiatrist should 
be aware of inborn errors of metabolism. In the literature, 
most relevant articles were found concerning ASD and psy-
chosis in combination with a metabolic disorder. Based on 
the literature an overview for the different psychiatric dis-
orders in the scoop of this paper was made in the combina-
tion with others signs and symptoms. This overview gives 
the child and adolescent psychiatrist some direction for fur-
ther investigations and referral to a metabolic unit.
In the literature search, no guidelines were found when 
to look for a metabolic disease in a child presenting with a 
psychiatric disorder. A broad metabolic screening or rou-
tine metabolic screening carriers a low yield [8]. A meta-
bolic work-up must be reserved for patients with clinical 
indicators of a metabolic disorder [8, 15, 66].
Further investigations are warranted in case of [3, 8, 15]:
 – A positive family history of metabolic disease.
 – Symptoms or signs are triggered by food intake (esp 
high protein content foods), fever, fasting, surgery 
(catabolism).
 – Feeding difficulties, food refusal, failure to thrive, eat-
ing disorders combined with symptoms of myopathy or 
fatigue.
 – Mental retardation and/or regression.
 – Epilepsy, episodes of lethargy or confusion.
 – Dysmorphic feature.
In most cases, there is a combination of neurological 
signs (epilepsy, ataxia, and catatonia), cognitive and motor 
dysfunction (hypotonia, hypertonia) and systemic signs of 
diverse organic involvement, cardiomyopathy, liver dys-
function, renal problems, immune deficiency, anaemia, 
and gastrointestinal problems (diarrhoea, obstipation, and 
pseudo-obstruction).
In this review, we did not include depression and anxi-
ety disorders. The reason for this is that the focus of this 
review is on metabolic disorders as a comorbidity sharing 
similar pathogenesis, and a child psychiatric disorder being 
a clue to think about a metabolic disorder. In clinical prac-
tice, we see depression and anxiety after the diagnosis of a 
metabolic disorder, but rarely as a predictor of a metabolic 
disorder [1, 4]. Nevertheless, in the process of the literature 
search, we found a few metabolic diseases presenting with 
depressive episodes or anxiety such as Wilson disease and 
AIP [4] (see also Table 5).
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This review is written from the perspective of a child 
and adolescent psychiatrist. The literature shows us that 
psychiatric diseases in adulthood can also reveal a meta-
bolic disorder [3]. For instance, postpartum psychosis 
can be caused by a urea cycle disorder [67–69] and by 
GM2 gangliosidosis [70] and psychosis is also described 
in methylenetetrahydrofolate reductase deficiency 
(MTHFR) [71]. Therefore, knowledge of metabolic dis-
ease and their psychiatric manifestations is also war-
ranted for adult psychiatrists. Finally, we hope to encour-
age the inclusion of inborn errors of metabolism in the 
differential diagnosis of psychiatric disease when appro-
priate as to allow and facilitate a prompt and correct 
diagnosis, followed by an effective treatment.
Table 4  Possible underlying metabolic disease in learning disorders
Associated signs and symptoms Possible underlying metabolic disease Other symptoms and signs of the 
metabolic disease




Glutaric aciduria type 1
Mucopolysaccharidosis
Type III (Sanfilippo syndrome)
Variable phenotype, deterioration 
in school performance, dementia, 
vision loss, sensorineural hearing 
loss, brain white matter abnormali-
ties on MRI, adrenal insufficiency
Progressive neurodegeneration. Non-
verbal learning disability syndrome, 
spasticity, brain white matter abnor-
malities, peripheral neuropathy
Acute regression after an initial 
phase of (almost) normal devel-
opment (acute encephalopathic 
crisis), severe dystonic-dyskinetic 
movement disorder, macrocephaly, 
MRI of the brain: fronto-temporal 
atrophy
Developmental or speech delay after 
a period of normal development, 
behaviour problems, hyperactivity, 
mild facial dimorphism, frequent 




6 months to 2 years
Childhood
Seizures Untreated PKU




Juvenile neuronal ceroid lipofusci-
nosis
Autism, ADHD, mental retardation, 
executive impairment
Delayed development in infancy with 
acquired microcephaly (cerebral/
cerebellar atrophy), ataxia
Hypoglycaemia, weakness, shakiness, 
rapid pulse, confusion
Hepatomegaly, abnormal hair, hepatic 
fibrosis, intellectual and develop-
mental disabilities, learning disabili-
ties, tone change, reflex abnormali-
ties, vomiting
Progressive deterioration of cogni-
tion, ataxia, spasticity, vision 







Vomiting and/or diarrhoea Galactosemia
Urea cycle disorders
Mucopolysaccharidosis
Type III (Sanfilippo syndrome)
Lethargy, vomiting, diarrhoea, failure 
to thrive, jaundice, cataract, speech 
difficulties, learning disorders, 
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Table 5  Possible underlying metabolic diseases in psychosis
Associated signs 
and symptoms
Possible underlying metabolic 
disease
Other symptoms and signs of the metabolic 
disease
Onset of the metabolic disease
Seizures Mitochondrial disorders




Central nervous system dysfunction, behavioural 
disturbance, cognitive impairment, motor distur-
bances, autism
Anxiety, restlessness, insomnia, neuropathy, 
psychosis, aggressive and impulsive behaviour, 
catatonia, intestinal problems, dark urine, skin 
lesions, epilepsy, acute peripheral neuropathy
Hepatomegaly, abnormal hair, hepatic fibrosis, 
intellectual and developmental disabilities, 
learning disabilities, confusion, delusion, seizure 
disorders, muscle tone change, reflex abnormali-
ties, vomiting, changing food habits, headache
Mild or severe depending on the enzyme activity: 
encephalopathy, gait disturbance, parapare-
sis, arterial or venous thrombosis and strokes, 










Immune deficiency, facial and skeletal abnormali-
ties, hearing impairment, intellectual disability, 
progressive neurological signs, episodes of 
confusion and psychosis followed by a period of 
confusion, somnolence and asthenia
Hepatosplenomegaly, cerebellar ataxia, dysar-
thria, vertical gaze palsy, cognitive difficulties, 
progressive neurological deterioration, psychotic 
symptoms, schizophrenia, behavioural distur-
bances (aggressiveness, self-mutilation, social 
isolation, laughing), depressive episodes, bipolar 
disorders, obsessive–compulsive disorders, 
infantile cholestatic icterus
Lens dislocation, Marfan-like appearance, throm-
boembolic events, schizophrenia or psychotic 
episodes (rare), behavioural disorders, depres-
sion, obsessive–compulsive disorder, disorgan-
ized behaviour, delusions, depression, alteration 
of consciousness, peripheral neuropathy, coma, 
paraplegia, strokes, thromboembolic events
Infancy






Sandhoff disease or GM2 gangli-
osidosis
Niemann–Pick type C Homocyst-
inuria
Ophtalmology: Kayser-Fleisher rings mood 
disorders, behavioural and personality disorders, 
cognitive impairment, psychotic symptoms, 
dysarthria, anxiety
Neural pain in hands and feet, cornea verticil-
lata, hearing loss, stroke, renal dysfunction, 
proteinuria, asymmetric cardiac hypertrophy, 
angiokeratoma
Speech and swallowing difficulties, unsteadiness 
of gait, spasticity, dystonia, cognitive decline, 
schizophrenia like psychosis, depression, mania, 
lower motor neuron disease, sensitive polyneu-
ropathy, dysautonomia, spastic fright reaction,  
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